Doctor’s Brief · free to read

Important updates for UK doctors, made useful in five minutes.

Pay and work changes. Career deadlines. Medical advances. Every brief shows its scope, last-check date and original sources—plus what the headline does not prove.

Pay & work

What changed—and what to check.

Each article adds a bounded checklist or date summary while leaving personalised analysis to the relevant Passport.

Official-source checklist5 min

Starting a new rotation? Check these first-payslip basics

A bounded first read of basic pay, role details, additions, deductions and records—before deciding whether anything needs investigation.

UK checklist · contract rules vary by nation and roleChecked 10 August 2026
Read brief
NHS England update4 min

Course expenses: what the NHS 4–6 week standard actually says

What NHS England asked trusts to improve, the latest reported progress and the records worth keeping when you submit a claim.

England · local policy still appliesChecked 10 August 2026
Read brief

Career & evidence

Deadlines and evidence, without the noise.

Each article adds a bounded checklist or date summary while leaving personalised analysis to the relevant Passport.

Official recruitment update4 min

350+ additional training places: who should check now

A time-sensitive guide to the new February 2027 posts, reserve-list preferencing and the Round 3 route.

England · February 2027 startsChecked 10 August 2026
Read brief
Official recruitment dates5 min

2027 specialty recruitment: the national dates to know now

Round 1, Round 2, Round 3 and ACF dates from the official national timeline, with the limits that still require a specialty-specific check.

National recruitment timeline · specialty details varyChecked 10 August 2026
Read brief

Medical advances

New evidence, separated from the headline.

Trial design, UK status and uncertainty are shown separately. These are professional education summaries, not clinical guidance.

NICE recommended · primary trial linked6 min

Teplizumab: what NICE’s type 1 diabetes decision changes

The first NICE-recommended therapy designed to delay progression from stage 2 to stage 3 type 1 diabetes—and the boundaries the headline can hide.

NICE TA1176 · England and Wales commissioning contextChecked 10 August 2026
Read brief
MHRA authorised · NICE recommended6 min

Aficamten for obstructive HCM: approval, evidence and NHS status

Why the 30 July 2026 MHRA and NICE decisions matter, what the phase 3 trial tested and where a short headline becomes misleading.

Adults with symptomatic obstructive HCMChecked 10 August 2026
Read brief

How we publish

Reliable sources first. A clear review before publication.

  1. 01
    Start with trusted sources

    Official UK bodies, trial registries and original peer-reviewed research—not an open-ended content scrape.

  2. 02
    Build a source pack

    Scope, date, population, decision status, endpoints, harms and limitations must be present before drafting.

  3. 03
    Check every claim

    Unsupported numbers, mixed UK nations, missing dates or unclear licensing/NICE status block publication.

  4. 04
    Approve before publishing

    No unreviewed medical posts, doses, prescribing instructions, patient-specific recommendations or invented CPD evidence.

Doctor’s Brief is published by Doctor’s Passport. Some articles link to planned paid Passport services. Those links are labelled and do not change the editorial summary.